SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-24-218683
Filing Date
2024-09-13
Accepted
2024-09-13 12:46:50
Documents
8
Period of Report
2024-09-13

Document Format Files

Seq Description Document Type Size
1 6-K d822844d6k.htm 6-K 10278
2 EX-99.1 d822844dex991.htm EX-99.1 52315
3 EX-99.2 d822844dex992.htm EX-99.2 38028
4 EX-99.3 d822844dex993.htm EX-99.3 26595
5 GRAPHIC g822844dsp10.jpg GRAPHIC 2254
6 GRAPHIC g822844g0913155540161.jpg GRAPHIC 2601
7 GRAPHIC g822844g0913155540503.jpg GRAPHIC 2328
8 GRAPHIC g822844g0913155540723.jpg GRAPHIC 2042
  Complete submission text file 0001193125-24-218683.txt   141759
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

IRS No.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 241297109
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)